NO922376L - Insulinanaloger - Google Patents

Insulinanaloger

Info

Publication number
NO922376L
NO922376L NO92922376A NO922376A NO922376L NO 922376 L NO922376 L NO 922376L NO 92922376 A NO92922376 A NO 92922376A NO 922376 A NO922376 A NO 922376A NO 922376 L NO922376 L NO 922376L
Authority
NO
Norway
Prior art keywords
insulin analogues
analogues
insulin
Prior art date
Application number
NO92922376A
Other languages
English (en)
Norwegian (no)
Other versions
NO922376D0 (no
Inventor
David Nettleship Brems
Ronald Eugene Chance
Bruce Hill Frank
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO922376D0 publication Critical patent/NO922376D0/no
Publication of NO922376L publication Critical patent/NO922376L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO92922376A 1991-06-21 1992-06-17 Insulinanaloger NO922376L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71857491A 1991-06-21 1991-06-21

Publications (2)

Publication Number Publication Date
NO922376D0 NO922376D0 (no) 1992-06-17
NO922376L true NO922376L (no) 1992-12-22

Family

ID=24886590

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922376A NO922376L (no) 1991-06-21 1992-06-17 Insulinanaloger

Country Status (17)

Country Link
EP (1) EP0519750A3 (sh)
JP (1) JPH05271283A (sh)
CN (1) CN1069737A (sh)
AU (1) AU1837792A (sh)
BR (1) BR9202322A (sh)
CA (1) CA2071382A1 (sh)
CZ (1) CZ186492A3 (sh)
FI (1) FI922882A (sh)
HU (1) HUT61581A (sh)
IE (1) IE921997A1 (sh)
IL (1) IL102240A0 (sh)
MX (1) MX9202987A (sh)
NO (1) NO922376L (sh)
NZ (1) NZ243229A (sh)
TW (1) TW222643B (sh)
YU (1) YU64192A (sh)
ZA (1) ZA924448B (sh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT71583A (en) * 1992-12-18 1995-12-28 Lilly Co Eli Insulin-analogs
US20020111461A1 (en) 1999-05-21 2002-08-15 Todd C. Somers Low molecular weight peptidomimetic growth hormone secretagogues
DE60120372T2 (de) 2000-03-24 2007-07-05 Genentech Inc., San Francisco Verwendung von insulin zur behandlung von knorpelkrankheiten
JPWO2006093222A1 (ja) * 2005-03-02 2008-08-07 味の素株式会社 インスリンの多量体形成阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DE10075034I1 (de) * 1987-02-25 2001-05-23 Novo Nordisk As Insulinderivate
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
PT93057B (pt) * 1989-02-09 1995-12-29 Lilly Co Eli Processo para a preparacao de analogos da insulina

Also Published As

Publication number Publication date
IE921997A1 (en) 1992-12-30
NZ243229A (en) 1994-09-27
CZ186492A3 (en) 1993-01-13
FI922882A (fi) 1992-12-22
AU1837792A (en) 1992-12-24
TW222643B (sh) 1994-04-21
MX9202987A (es) 1993-01-01
IL102240A0 (en) 1993-01-14
HUT61581A (en) 1993-01-28
FI922882A0 (fi) 1992-06-18
EP0519750A3 (en) 1993-06-23
NO922376D0 (no) 1992-06-17
EP0519750A2 (en) 1992-12-23
HU9202048D0 (en) 1992-09-28
JPH05271283A (ja) 1993-10-19
CA2071382A1 (en) 1992-12-22
YU64192A (sh) 1994-06-10
ZA924448B (en) 1993-12-17
CN1069737A (zh) 1993-03-10
BR9202322A (pt) 1993-01-19

Similar Documents

Publication Publication Date Title
DE69222622T2 (de) Spritze
DE68912777T2 (de) Insulin-analoge.
FI104235B1 (fi) Ruisku
BR9306987A (pt) Seringa retrátil
DK186089A (da) Sproejter
BR9200984A (pt) Inalador
KR920017793U (ko) 드로우어웨이 팁
DK0510687T3 (da) Infusionspræparation
FI921435A (fi) Skydd foer saenkpump i svaora foerhaollanden
FI922759A (fi) Loesningsmedelskompositioner foer anvaendning i tryckkaensligt kopieringspapper
FI953001A (fi) Insuliinianalogeja
FI943581A0 (fi) Ruisku
DE59205539D1 (de) Fördermittel
FI934710A0 (fi) 4-aryl-3-(heteroarylureido)kinolinderivat
NO922376D0 (no) Insulinanaloger
DK137191A (da) Insulinpraeparat
FI920998A (fi) Skaermad hytt i modulkonstruktion
KR920021041U (ko) 세척기
NO933064D0 (no) Hetero-antracyklin-antitumor-analoger
FI922714A (fi) Anordning i en sf6-isolerad hoegspaenningslindningskopplare
FI916087A (fi) Anordning i en produktionslinje foer mineralull
NO942783D0 (no) Spröyte
NO950721L (no) Insulinanaloger
ATE100824T1 (de) Insulin-analoge.
NO904841D0 (no) Insulinanaloger.